Clinitech Laboratory
Clinitech Laboratory Share Price Chart
Clinitech Laboratory last traded at ₹32.00 (2026-10-13). Over the past month the stock moved -8.8%, three months the stock moved -20.8%, year the stock moved -20.6%. Its closing range over 52 weeks is ₹31.72 – ₹47.15, with the latest close 32.1% below the high.
Closing prices up to 2026-10-13.
About Clinitech Laboratory
Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.[1]
Business Overview:[1] CTLL in the business of providing NABL accredited healthcare services such as: a) Pathology testing labs b) Diagnostic centres c) Scan centres d) X-ray centres e) ECG clinics
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Clinitech Laboratory reported sales of ₹4.39 crore (+31.4%) and net profit of ₹0.12 crore (-60.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4.39 | 0.45 | 10.25 | 0.12 | 0.53 |
| Sep 2025 | 5.08 | 0.54 | 10.63 | 0.30 | 1.31 |
| Mar 2025 | 4.16 | 0.28 | 6.73 | 0.17 | 0.74 |
| Sep 2024 | 4.08 | 0.56 | 13.73 | 0.22 | 0.96 |
| Mar 2024 | 3.34 | 0.73 | 21.86 | 0.30 | 1.79 |
| Sep 2023 | 3.06 | 0.28 | 9.15 | 0.07 | 0.47 |
| Sep 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +66.0% | +31.4% |
| Operating profit growth | +92.9% | -38.4% |
| Net profit growth | +328.6% | -60.0% |
| EPS growth | +178.7% | -70.4% |
| OPM % | 10.6% | 10.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Clinitech Laboratory reported sales of ₹9.48 crore (+15.2%) and net profit of ₹0.42 crore (+7.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 9.48 | 0.99 | 10.44 | 0.42 | 1.84 |
| Mar 2025 | 8.23 | 0.83 | 10.09 | 0.39 | 1.71 |
| Mar 2024 | 6.40 | 0.99 | 15.47 | 0.37 | 2.20 |
| Mar 2023 | 6.35 | 1.36 | 21.42 | 0.61 | 4.07 |
| Mar 2022 | 6.38 | 1.07 | 16.77 | 0.51 | 3.40 |
| Mar 2021 | 4.55 | 0.83 | 18.24 | 0.40 | 6.00 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales growth | +40.2% | -0.5% | +0.8% | +28.6% | +15.2% |
| Operating profit growth | +28.9% | +27.1% | -27.2% | -16.2% | +19.3% |
| Net profit growth | +27.5% | +19.6% | -39.3% | +5.4% | +7.7% |
| EPS growth | -43.3% | +19.7% | -45.9% | -22.3% | +7.6% |
| OPM % | 16.8% | 21.4% | 15.5% | 10.1% | 10.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Clinitech Laboratory.
Get Free AI Stock Analysis FREE →Latest News
-
Clinitech Laboratory enters into MoU with M/s. MDM Dawudi Hospital
-
Clinitech Laboratory enters into MoU with M/s. MDM Dawudi Hospital
-
Clinitech Laboratory enters into MoU with M/s. MDM Dawudi Hospital
Frequently Asked Questions
What is the share price of Clinitech Laboratory today?
Clinitech Laboratory shares were last quoted at ₹32.00 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Clinitech Laboratory?
Clinitech Laboratory has a price-to-earnings (P/E) ratio of 19.29 and a price-to-book (P/B) ratio of 0.87. The industry P/E is 102.95.
What is the 52-week high and low of Clinitech Laboratory?
The 52-week high of Clinitech Laboratory is ₹57.00 and the 52-week low is ₹28.55.
What is the market cap of Clinitech Laboratory?
The market capitalisation of Clinitech Laboratory is about ₹8.01 crore.
How did Clinitech Laboratory perform in its latest quarterly results?
In the latest quarter (Mar 2026), Clinitech Laboratory reported sales of ₹4.39 crore (+31.4%) and net profit of ₹0.12 crore (-60.0%), compared with the same quarter last year.
Is Clinitech Laboratory a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Clinitech Laboratory has a 3-year ROE of 6.00%, 3-year profit growth of -12.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Clinitech Laboratory?
Promoters hold about 64.20% of Clinitech Laboratory.
Which sector does Clinitech Laboratory belong to?
Clinitech Laboratory belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z